NOVEL ENERGY ABSORBING MATERIALS WITH APPLICATIONS IN HELMETED HEAD PROTECTION

A finite element, functionally graded foam model (FGFM) is proposed, which is shown to provide more effective energy absorption management, compared to homogenous foams, under low energy impact conditions. The FGFM is modelled by discretising a virtual foam into a large number of element layers through the foam thickness. Each layer is described by a unique constitutive cellular response, which is derived from the initial foam density, ρ, unique to that layer. Large strain unixial compressive tests at a strain rate of 0.001 s-1 are performed on expanded polystyrene (EPS), and their σ −ε response is used as input to a modified constitutive model from the literature. It is found that under low energy impacts an FGFM can outperform a uniform foam of equivalent density terms of reducing peak accelerations, while performing almost as effectively as uniform foams under high energy conditions. These novel materials, properly manufactured, could find use as next generation helmet liners in answer to recent, more rigorous equestrian helmet standards, e.g. BS EN 14572:2005

HAVE WE REACHED PEAK DESIGN THINKING? Are we entering a new paradigm for how it is used within practice and business?

Design Thinking has gained recognition as an acclaimed process for generating innovative, human centred solutions at a social and business level. It has also gained notoriety amongst many designers, who claim that its success as an exported element of the design process has resulted in its commodification, and led to it becoming a diluted series of processes that lack criticality. As design disciplines and the role of designers continue to evolve, we should reflect on design thinking’s original context and understand its progression into a non-design world. Our hypothesis is that design thinking has reached a ‘peak’ in contemporary practice, and as the term 'design' is further adapted and conformed to suit a business function, this conversational will elicit a constructive debate on the future of design thinking and its positioning within design and non-design industries. Has Design Thinking’s commodification and consumption as a step by step road map to innovation reduced it to a mainstream approach? Can we use the undoubted successes of design thinking as a catalyst for future design research? It is anticipated that through analysis and discussion, this conversation will inform the conceptualisation of enhanced methodological frameworks that aim to support innovation across divergent industry practices

Reframing e-assessment: building professional nursing and academic attributes in a first year nursing course

This paper documents the relationships between pedagogy and e-assessment in two nursing courses offered at the University of Southern Queensland, Australia. The courses are designed to build the academic, numeracy and technological attributes student nurses need if they are to succeed at university and in the nursing profession. The paper first outlines the management systems supporting the two courses and how they intersect with the e-learning and e-assessment components of course design. These pedagogical choices are then reviewed. While there are lessons to be learnt and improvements to be made, preliminary results suggest students and staff are extremely supportive of the courses. The e-assessment is very positively received with students reporting increased confidence and competency in numeracy, as well as IT, academic, research and communication skills

Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study)

Background: Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disorder of the human motor system. Neuroinflammation appears to be an important modulator of disease progression in ALS. Specifically, reduction of regulatory T cell (Treg) levels, along with an increase in pro-inflammatory effector T cells, macrophage activation and upregulation of co-stimulatory pathways have all been associated with a rapid disease course in ALS. Autologous infusion of expanded Tregs into sporadic ALS patients, resulted in greater suppressive function, slowing of disease progression and stabilization of respiratory function. Tecfidera (dimethyl fumarate) increases the ratio of anti-inflammatory (Treg) to proinflammatory T-cells in patients with relapsing remitting multiple sclerosis and rebalances the regulatory: inflammatory axis towards a neuroprotective phenotype. Consequently, the aim of this study was to assess the efficacy, safety, and tolerability of Tecfidera in sporadic ALS. Methods: The study is an investigator led Phase 2 multi-center, randomized, placebo controlled, double blind clinical trial assessing the efficacy and safety of Tecfidera in patients with sporadic ALS. The study duration is 40 weeks, with a 36-week study period and end of study visit occurring at 40 weeks or at early termination/withdrawal from study. The TEALS study has been registered with the Australian and New Zealand Clinical Trials registry (ANZCTR) under the trials registration number ACTRN12618000534280 and has been approved by the Human Research Ethics Committee and Research Governance Office at the lead site (Westmead Hospital) with the ethics number HREC/17/WMEAD/353. The participating sites have obtained site specific ethics and governance approvals from the local institution. Results: The primary endpoint is slowing of disease progression as reflected by the differences in the ALS Functional Rating Score-Revised (ALSFRS-R) score at Week 36. The secondary endpoints will include effects in survival, lower motor neuron function, respiratory function, quality of life and safety. Conclusion: This Phase 2 multi-center, randomized, placebo controlled, double blind clinical trial will provide evidence of efficacy and safety of Tecfidera in sporadic ALS

Dielectronic Recombination of Ground-State and Metastable Li+ Ions

Dielectronic recombination has been investigated for Delta-n = 1 resonances of ground-state Li+(1s^2) and for Delta-n = 0 resonances of metastable Li+(1s2s ^3S). The ground-state spectrum shows three prominent transitions between 53 and 64 eV, while the metastable spectrum exhibits many transitions with energies < 3.2 eV. Reasonably good agreement of R-matrix, LS coupling calculations with the measured recombination rate coefficient is obtained. The time dependence of the recombination rate yields a radiative lifetime of 52.2 +- 5.0 s for the 2 ^3S level of Li+.Comment: Submitted to Phys. Rev. A; REVTeX, 4 pages, 3 figure

Experimental observation and theoretical calculations of rydberg series in hollow lithium atomic states

Several extended Rydberg series have been experimentally identified in triply excited states of hollow lithium, by use of electron spectrometry and synchrotron radiation at the Advanced Light Source. Energies, partial cross sections, and quantum defects have also been calculated using the R-matrix approximation. Our results show that the two inner electrons stay in a core-excited state of given symmetry while the behavior of the third electron is mostly governed by the nuclear potential screened by the two inner electrons

Photoelectron spectroscopy measurements and theoretical calculations of the lowest doubly hollow lithium state

We have measured, using electron spectroscopy, the lowest-energy doubly hollow lithium triply excited (3l3l′3l″) 2P state. Energies, widths, and partial cross sections have been measured and calculated using the saddle-point technique and the R-matrix approximation. Our results show good agreement between experimental and theoretical data for the energy and the width of the doubly hollow state

Maternal psychological distress in primary care and association with child behavioural outcomes at age three

Observational studies indicate children whose mothers have poor mental health are at increased risk of socio-emotional behavioural difficulties, but it is unknown whether these outcomes vary by the mothers’ mental health recognition and treatment status. To examine this question, we analysed linked longitudinal primary care and research data from 1078 women enrolled in the Born in Bradford cohort. A latent class analysis of treatment status and self-reported distress broadly categorised women as (a) not having a common mental disorder (CMD) that persisted through pregnancy and the first 2 years after delivery (N = 756, 70.1 %), (b) treated for CMD (N = 67, 6.2 %), or (c) untreated (N = 255, 23.7 %). Compared to children of mothers without CMD, 3-year-old children with mothers classified as having untreated CMD had higher standardised factor scores on the Strengths and Difficulties Questionnaire (d = 0.32), as did children with mothers classified as having treated CMD (d = 0.27). Results were only slightly attenuated in adjusted analyses. Children of mothers with CMD may be at risk for socio-emotional and behavioural difficulties. The development of effective treatments for CMD needs to be balanced by greater attempts to identify and treat women. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00787-015-0777-2) contains supplementary material, which is available to authorized users

Improved Survival after Heart Failure: A Community-based Perspective

Background: Heart failure is a highly prevalent, morbid, and costly disease with a poor long-term prognosis. Evidence-based therapies utilized over the past 2 decades hold the promise of improved outcomes, yet few contemporary studies have examined survival trends in patients with acute heart failure. Objectives: The primary objective of this population-based study was to describe trends in short and long-term survival in patients hospitalized with acute decompensated heart failure (ADHF). A secondary objective was to examine patient characteristics associated with decreased long-term survival. Methods and Results: We reviewed the medical records of 9,748 patients hospitalized with ADHF at all 11 medical centers in central Massachusetts during 1995, 2000, 2002, and 2004. Patients hospitalized with ADHF were more likely to be elderly and to have been diagnosed with multiple comorbidities in 2004 compared with 1995. Over this period, survival was significantly improved in-hospital, and at 1, 2, and 5 years post-discharge. Five-year survival rates increased from 20% in 1995 to 28% in 2004. Although survival improved substantially over time, older patients and patients with chronic kidney disease, chronic obstructive pulmonary disease, anemia, low body mass index, and low blood pressures had consistently lower post-discharge survival rates than patients without these comorbidities. Conclusion: Between 1995 and 2004, patients hospitalized with ADHF have become older and increasingly comorbid. Although there has been a significant improvement in survival among these patients, their long-term prognosis remains poor, as fewer than 1 in 3 patients hospitalized with ADHF in 2004 survived more than 5 years